Scientific Publications

Search by Keyword(s)
Found 5 results

Filters: Author is Kool, M  [Clear All Filters]

Search Results

  • Showing 1-5 of 5 Results
2014
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition.Kool, M., Jones DT, Jäger N., Northcott PA, Pugh TJ, Hovestadt V., Piro RM, Esparza LA, Markant SL, Remke M., Milde T., Bourdeaut F., Ryzhova M., Sturm D., Pfaff E., Stark S., Hutter S., Seker-Cin H., Johann P., Bender S., et al. Cancer cell, 2014/03/17, Volume 25, Issue 3, p.393-405, (2014) Read More / View Supplemental Materials
Abstract
2013
Signatures of mutational processes in human cancer.Alexandrov, LB, Nik-Zainal S., Wedge DC, Aparicio SA, Behjati S., Biankin AV, Bignell GR, Bolli N., Borg A., Børresen-Dale AL, Boyault S., Burkhardt B., Butler AP, Caldas C., Davies HR, Desmedt C., Eils R., Eyfjörd JE, Foekens JA, Greaves M., et al. Nature, 2013/08/22, Volume 500, Issue 7463, p.415-21, (2013) Read More / View Supplemental Materials
Abstract
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma.Zhukova, N., Ramaswamy V., Remke M., Pfaff E., Shih DJ, Martin DC, Castelo-Branco P., Baskin B., Ray PN, Bouffet E., von Bueren AO, Jones DT, Northcott PA, Kool M., Sturm D., Pugh TJ, Pomeroy SL, Cho YJ, Pietsch T., Gessi M., et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013/07/08, (2013) Read More / View Supplemental Materials
Abstract
2011
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.Cho, YJ, Tsherniak A., Tamayo P., Santagata S., Ligon A., Greulich H., Berhoukim R., Amani V., Goumnerova L., Eberhart CG, Lau CC, Olson JM, Gilbertson RJ, Gajjar A., Delattre O., Kool M., Ligon K., Meyerson M., Mesirov J. P., and Pomeroy SL Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011/04/10, Volume 29, Issue 11, p.1424-30, (2011) Read More / View Supplemental Materials
Abstract
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features.Tamayo, P., Cho YJ, Tsherniak A., Greulich H., Ambrogio L., Schouten-van Meeteren N., Zhou T., Buxton A., Kool M., Meyerson M., Pomeroy SL, and Mesirov J. P. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011/04/10, Volume 29, Issue 11, p.1415-23, (2011) Read More / View Supplemental Materials
Abstract
  • Showing 1-5 of 5 Results